In this patient, a systematic diagnostic approach - recognition of the TMA triad, exclusion of TTP (via normal ADAMTS13 activity), and identification of potential drug exposure - led to a final diagnosis of drug-induced atypical HUS. This evidence concerns the gene ADAMTS13 and hemolytic-uremic syndrome.